Publication Name	World Journal of Hepatology
Manuscript ID	99681
Country	India

Received	2024-07-27 15:39
Peer-Review Started	2024-07-27 15:39
To Make the First Decision
Return for Revision	2024-09-18 03:59
Revised	2024-09-26 19:01
Second Decision	2024-10-10 02:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-10 10:05
Articles in Press	2024-10-10 10:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-14 03:12
Publish the Manuscript Online	2024-10-21 07:03

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
Manuscript Source	Invited Manuscript
All Author List	Sudheer Marrapu and Ramesh Kumar
Funding Agency and Grant Number
Corresponding Author	Ramesh Kumar, MD, Department of Gastroenterology, All India Institute of Medical Sciences, Phulwari Sharif, Patna 801507, India. docrameshkr@gmail.com
Key Words	Chronic hepatitis B; Hepatitis B virus; Cirrhosis; Decompensation; Hepatocellular carcinoma
Core Tip	Hepatitis B remains a significant global health challenge. Despite ongoing efforts by the World Health Organization to eliminate hepatitis B as a public health concern by 2030, the situation on the ground is dire, with only about 13% of those infected diagnosed and merely 2.6% receiving treatment. In sub-Saharan Africa, awareness of hepatitis B virus infection is alarmingly low (1%), and many cases are identified only at the stage of cirrhosis, when the benefits of therapy are significantly reduced. This editorial aim to elucidate the challenges and explore potential strategies to improve the quality of care for such patients.
Publish Date	2024-10-21 07:03
Citation	<p>Marrapu S, Kumar R. Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return. <i>World J Hepatol</i> 2024; 16(10): 1151-1157</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i10/1151.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i10.1151

Full Article (PDF)	WJH-16-1151-with-cover.pdf
Manuscript File	99681_Auto_Edited_014552.docx
Answering Reviewers	99681-answering-reviewers.pdf
Audio Core Tip	99681-audio.mp3
Conflict-of-Interest Disclosure Form	99681-conflict-of-interest-statement.pdf
Copyright License Agreement	99681-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	99681-non-native-speakers.pdf
Peer-review Report	99681-peer-reviews.pdf
Scientific Misconduct Check	99681-scientific-misconduct-check.png
Scientific Editor Work List	99681-scientific-editor-work-list.pdf
CrossCheck Report	99681-crosscheck-report.pdf